According to the expression pattern during atherosclerosis progression in female Ldlr−/−Apob100/100 mice and the levels in female carotid plaques, the top key driver, CTSB, constitutes a plausible target to modify the activity of GRN122 in females (Fig. 7h, lower panels). The gene discussed is CTSB; the disease is atherosclerosis.